NMDP/Be The Match: Public & Payer Policy Updates

Slides:



Advertisements
Similar presentations
ICD-10: A Street View. 2 Agenda © 2013 TM Floyd & Company  Timelines for Compliance  Payers & Providers  Readiness Updates  Priorities.
Advertisements

Blood Product Reimbursement Report 4 th QuarterNovember 2009Volume 1, Number This information is provided as a service to assist hospitals and other.
LEUKEMIA & LYMPHOMA SOCIETY TEAM IN TRAINING. THE LEUKEMIA & LYMPHOMA SOCIETY WORLDS LARGEST VOLUNTARY HEALTH ORGANIZATION DEDICATED TO FUNDING BLOOD.
Costs, Charges and Reimbursements in BMT: Is there any Good News for the Future??? Costs, Charges and Reimbursements in BMT: Is there any Good News for.
Health Budgets & Financial Policy CY 2009 OIB Rate Package Release June 2009 Presented by UBO Project Support Team.
Building Canada’s National Public Cord Blood Bank.
Bone Marrow Transplant By ; Sabrina Caronia. Definition  Bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy.
Kelsey Cramer. MEET MY AUNT DONATING BONE MARROW.
LA Medicaid HEALTHCARE FINANCIAL MANAGEMENT ASSOCIATION PRESENTATION January 30, 2009.
Health Care Policy: What You Should Know American Nephrology Nurses Association (ANNA) Long Island Chapter, Fall Conference November 13, 2013 Carle Place,
Case for Support. Blood Cancers More than 1 million North Americans are fighting blood cancers, the third leading cause of cancer deaths. Early detection.
Second Annual Lymphoma Survivorship Conference. April 5, 2014.
STATE HEALTH PLAN REQUEST FOR REVIEW OF DONOR COVERAGE BENEFITS Presented by: S. Elizabeth Sharf August 2015.
Modernizing Clinical Communications, Analytics, and the Revenue Cycle Process in the Era of ACOs Jason Tipton, Director of Value Operations – Holston Medical.
1 THE LEUKEMIA & LYMPHOMA SOCIETY PRESENTATION AT CDC-HEMATOLOGIC CANCER ANNUAL MEETING MAY 16, 2008 ATLANTA, GEORGIA.
The Power of the Rare Disease Community… Diane Dorman Vice President, Public Policy National Organization for Rare Disorders (NORD) 1 st International.
Advocacy Efforts in Your Community. 2 Advocacy Agenda Key Takeaways Why is this Important? Who We Are Advocacy at WHC Future at State Level In Summary.
Introduction to the NHLBI Context. Agenda  Introduction to the NMDP / CIBMTR  Forms being curated  Progress update  Description of review process.
Patient Engagement throughout the Biopharmaceutical Lifecycle: Tips for Effective Patient Advocate/Industry Collaboration to Improve Patient Access and.
Successful Strategies of the Puzzle APHA 2007 New Minnesota Legislation, Sustaining the role of Community Health Workers.
CRITICAL ACCESS HOSPITALS. Balanced Budget Act of 1997 The BBA had a severe financial impact on hospitals around the country. To help alleviate the impact.
1 Transition to ICD-10 UC San Diego Health System 2015.
Cord Blood Presentation to the AZ House Health Committee Charis Ober Save the Cord Foundation January 12, 2016.
Kidney Community Advocacy Day 2017 Advocate Pre-Training
TRANSITIONAL CARE MANAGEMENT Codes 99495; CMMI September 2015
Whose Blood Is It, Anyway?
The Society for Cardiovascular Angiography and Interventions
Quality Improvement Program: Special Needs Plans
Patient engagement in Quality of Care Measurement
HOPING is a national education initiative of :
CJR McLeod Regional Medical Center
Georgia Enrollment Assistance Resource (GEAR) Network: GEARing up for OE3! Whitney Griggs & Pranay Rana October 19, 2015.
SOLVE WE CAN HUNGER TOGETHER
Novant Health Winston-Salem, NC.
Reimbursement Nutr 564: Summer 2002.
Hemic/Lymphatic System
HOPING is a national education initiative of :
Hemophilia Alliance Fall Meeting 2017
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
Common Insurance Challenges & Access Strategies for people with CF
American Clinical Laboratory Association
Presented by Joe Nichols MD Principal – Health Data Consulting
Benefits of Care Management
Cancer Resource Network
Parashar Patel Health Economics & Reimbursement Boston Scientific
ICD-10 Updates.
Robert Howey MBA, MHA, CPA Director, Toyon Associates
Medicare and Hospitals
NMDP Overview: Financial Resources
COPD Hospitalizations for Elderly Medicare Beneficiaries
Timing for HCT Consultation
10-CMSMDS-1 Study Training Slides
A Day in the Life of a HCT Financial Coordinator
Health and Human Services Information for Rural America
Giving New Voice An SCDAA Overview…..
CIBMTR 2019 What your work makes possible Bronwen Shaw
OHA update Ohio Hospital transparency
DRG Implementation Overview
Hospital Inpatient DRG Reconciliation Sandy Sage RN March 23, 2016.
OHA update Ohio Hospital transparency
DRGs + Four Factors in Hospital Improvement
Introduction to SIR’s Evaluation and Management Toolkit
A Population Level Analysis of Statewide Claims Data
Remaining Out-of-Pocket
Certified Community Behavioral Health Clinics
Timing for HCT Consultation
Kristen Edsall R.N., B.S.N., M.S.N. Manager, Payer Relations
CMS Studies – An Update CIBMTR Data Managers Meeting February 21, 2018
Our Mission… To ensure that all those impacted by cancer are empowered by knowledge, strengthened by action and sustained by community.
Financial Options when living with Cancer
Presentation transcript:

NMDP/Be The Match: Public & Payer Policy Updates 1/2/2019 NMDP/Be The Match: Public & Payer Policy Updates Susan Leppke, MPH & Alicia Silver, MPP September 27, 2017

Current PPP Priorities Appropriations Government Relationships Advocacy/Grassroots Medicare Coverage Medicare Reimbursement Health Economics Sickle Cell Disease Coding & Billing Communication to our Network

COVERAGE

Medicare Coverage Leukemia Aplastic Anemia Severe Combined Immunodeficiency Disease (SCID) Wiskott-Aldrich Syndrome Myelodysplastic Syndromes (MDS) Sickle Cell Disease Myelofibrosis Multiple Myeloma CED CED CED CED

Myelodysplastic Syndromes Current CEDs Opened in 2010 NCT #01166009 Myelodysplastic Syndromes Opened in 2016 aka BMT CTN 1503 (STRIDE2) NCT #02766465 Sickle Cell Disease NCT #02934477 Myelofibrosis NCT #03127761 Multiple Myeloma

Medicare CEDs Increase Patient Access to HCT

Medicare Coverage: Lymphoma

Medicare Coverage: Lymphoma 2015 Financial Barriers to HCT Survey: “Does your program transplant Medicare patients who have a disease indication that is not listed on the National Coverage Determination (NCD) and therefore have unknown reimbursement?” (n=56)

REIMBURSEMENT

Medicare Reimbursement: TC Impact 2017 Inpatient Reimbursement 2017 Outpatient Reimbursement Average NMDP Bone Marrow/PBSC Invoice Average NMDP Cord Blood Invoice $62,693 $27,752 $48,436 $65,117 $14,257 (Marrow/PBSC) -$2,424 (Cord Blood) -$20,684 (Marrow/PBSC) -$37,365

Medicare Reimbursement Overview New C-APC 5244

CODING & Billing

NEW ICD-10 PCS Crosswalk!

NEW Donation Process Coding & Billing Guide

Policy

Congressional Caucus to Cure Blood Cancers and Other Blood Disorders 1/2/2019 Congressional Caucus to Cure Blood Cancers and Other Blood Disorders Representative Gus Bilirakis (R-FL) Representative Doris Matsui (D-CA) Currently, Dear Colleague letter circulating throughout House of Representatives to solicit members

Medicare Reimbursement: FY17 Strategy Current Payment (FY17) MS-DRG 014: $69,844 Average Outlier*: $16,553 Total: $86,397 *Weighted average includes related and unrelated transplants Future Payment Modeled MS-DRG 014: $58,264 Projected Standard Acquisition Charges Related: $21,620 Marrow/PBSC: $48,436 Cord Blood: $65,117 Total: $79,884-$123,381* *Total could include an outlier payment but the calculation would not include the SAC, only charges for other charges and services.

Advocacy & grassroots

Advocacy Action Network 20,182 Advocates

Key Advocacy Successes OPPS CY 2017 Comment Letters to CMS 20 Health Professionals 7 Transplant Centers 29 Patients 347 Advocates IPPS FY 2018 Comment Letters to CMS 68 Health Professionals 141 Transplant Centers 51 Patients 1,202 Advocates 2017 Appropriations Letters to MoC 4,114 Advocates

Nmdp grants

Patient Services Grants Family Typing Grant Search Assistance Fund Transplant Support Assistance Funds John & Caryn Camiolo Survivorship Grant patientgrants@nmdp.org

Jason Carter Clinical Trials Program The Jason Carter Clinical Trials Program was created for patients and their families, to make it easier to find and join clinical trials. Funding was provided by the Carter family, in memory of their son and brother, Jason Carter who passed away May 2016 at age 28 from leukemia. This program provides: Easy-to-use web-based search tool to find relevant clinical trials. www.jasoncarterclinicaltrialsprogram.com. The trial descriptions are taken directly from clinicaltrials.gov and written in plain language for better patient comprehension Clinical Trials Patient Education Specialist available by phone and email to provide one-on-one support for patients and families by answering questions and helping navigate their specific clinical trials search. Educational resources for patients and families to help them learn about clinical trials

Take Action Stay up-to-date by joining the Advocacy Action Network. BeTheMatch.org/Advocacy Contact Us: Legislation@nmdp.org Can’t get enough HCT policy information? Subscribe to our monthly Reimbursement eNews Contact Us: payerpolicy@nmdp.org

Questions?

Thank you. Susan Leppke sleppke@nmdp. org Alicia Silver alicia Thank you! Susan Leppke sleppke@nmdp.org Alicia Silver alicia.silver@nmdp.org